USANA Health Sciences (NYSE:USNA) Price Target Cut to $46.00 by Analysts at DA Davidson

USANA Health Sciences (NYSE:USNA) had its price target trimmed by DA Davidson from $48.00 to $46.00 in a research report released on Tuesday, Benzinga reports. The brokerage currently has a neutral rating on the stock. DA Davidson also issued estimates for USANA Health Sciences’ Q2 2024 earnings at $0.68 EPS.

Separately, StockNews.com upgraded shares of USANA Health Sciences from a buy rating to a strong-buy rating in a research report on Friday, January 12th.

USANA Health Sciences Price Performance

Shares of USANA Health Sciences stock opened at $44.74 on Tuesday. USANA Health Sciences has a 1-year low of $41.45 and a 1-year high of $69.60. The stock has a market cap of $858.91 million, a P/E ratio of 13.94, a P/E/G ratio of 1.38 and a beta of 0.94. The stock’s 50 day simple moving average is $46.48 and its 200-day simple moving average is $48.07.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.35. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. The company had revenue of $221.08 million during the quarter, compared to analysts’ expectations of $206.70 million. As a group, research analysts expect that USANA Health Sciences will post 2.75 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO G Doug Iiekking sold 5,198 shares of the company’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total value of $232,662.48. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, Chairman Kevin Guest sold 11,011 shares of USANA Health Sciences stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $49.00, for a total value of $539,539.00. Following the completion of the sale, the chairman now owns 10,491 shares in the company, valued at approximately $514,059. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO G Doug Iiekking sold 5,198 shares of the company’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total value of $232,662.48. The disclosure for this sale can be found here. Over the last three months, insiders sold 34,286 shares of company stock worth $1,634,010. Company insiders own 0.33% of the company’s stock.

Institutional Investors Weigh In On USANA Health Sciences

Several institutional investors and hedge funds have recently modified their holdings of the company. Quest Partners LLC purchased a new stake in USANA Health Sciences during the fourth quarter worth about $66,000. CWM LLC grew its holdings in shares of USANA Health Sciences by 49.6% in the fourth quarter. CWM LLC now owns 1,267 shares of the company’s stock valued at $68,000 after purchasing an additional 420 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in USANA Health Sciences by 60.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock worth $198,000 after buying an additional 1,274 shares during the period. Trexquant Investment LP acquired a new stake in USANA Health Sciences during the 4th quarter worth approximately $266,000. Finally, Teacher Retirement System of Texas purchased a new position in USANA Health Sciences in the 3rd quarter valued at approximately $297,000. Hedge funds and other institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.